These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6221689)

  • 1. Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.
    Rylander M; Norrby SR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):352-5. PubMed ID: 6221689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on some variables influencing aminoglycoside efficacy in vivo and in vitro.
    Rylander M; Brorson JE; Holm SE; Norrby R
    Scand J Infect Dis; 1981; 13(3):217-25. PubMed ID: 6797055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N
    Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
    Digranes A; Dibb WL; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro and in vivo activity of ciprofloxacin.
    Zeiler HJ; Grohe K
    Eur J Clin Microbiol; 1984 Aug; 3(4):339-43. PubMed ID: 6237902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of norfloxacin.
    Norrby SR; Jonsson M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Static and dynamic properties of tissue cage fluid in rabbits.
    Bergholm AM; Henning C; Holm SE
    Eur J Clin Microbiol; 1984 Apr; 3(2):126-30. PubMed ID: 6723635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
    Stucki A; Cottagnoud M; Acosta F; Egerman U; Laeuffer JM; Cottagnoud P
    J Antimicrob Chemother; 2012 Mar; 67(3):661-5. PubMed ID: 22178642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
    Nakamura S; Nakata K; Katae H; Minami A; Kashimoto S; Yamagishi J; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 May; 23(5):742-9. PubMed ID: 6223579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
    Guerra JG; Falconi E; Palomino JC; Benavente L; Antunez de Mayolo E
    Eur J Clin Microbiol; 1983 Jun; 2(3):260-5. PubMed ID: 6224684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
    Tenney JH; Maack RW; Chippendale GR
    Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
    Body BA; Fromtling RA; Shadomy S; Shadomy HJ
    Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.